Basic Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Sep 7, 2023; 29(33): 4975-4990
Published online Sep 7, 2023. doi: 10.3748/wjg.v29.i33.4975
Figure 1
Figure 1 Pathological changes in mouse liver tissues after rAAV-Angiotensin-converting enzyme 2 treatment (magnification × 100). A: Effect of rAAV-ACE2 treatment on liver fibrosis in mice was assessed by Hematoxylin and eosin staining; B: Effect of rAAV-ACE2 treatment on liver fibrosis in mice was assessed by Masson trichrome staining; C: Effect of rAAV-ACE2 treatment on liver fibrosis in mice was assessed by Sirius red staining; D: The quantity of collagen production in each group was analyzed using Image-Pro Plus 6.0. aP < 0.01 vs Control; bP < 0.05 vs CCl4; cP < 0.05 vs rAAV-ACE2 + CCl4. Rapa: Rapamycin; ACE2: Angiotensin-converting enzyme 2.